EUVIMEDEUVIMED entdecken
Crossref

Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide

Michael Egger, Lacey McNally, Jonathan Nitz, Kelly M McMasters, Jorge G Gomez-Gutierrez

Human Gene Therapy Clinical Development · 2014

DOI: 10.1089/hum.2014.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy Clinical Development, 2014. Verfasst von Michael Egger und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Louisville, Surgery, Louisville, Kentucky, United States ; michael.egger@louisville.edu. Die Arbeit nennt 1 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • University of Louisville, Surgery, Louisville, Kentucky, United States ; michael.egger@louisville.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Egger, M., McNally, L., Nitz, J., McMasters, K. M., & Gomez-Gutierrez, J. G. (2014). Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Human Gene Therapy Clinical Development. https://doi.org/10.1089/hum.2014.022

Vancouver

Egger M, McNally L, Nitz J, McMasters KM, Gomez-Gutierrez JG. Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Human Gene Therapy Clinical Development. 2014. doi:10.1089/hum.2014.022

BibTeX
@article{Egger2014,
  author = {Egger, Michael and McNally, Lacey and Nitz, Jonathan and McMasters, Kelly M and Gomez-Gutierrez, Jorge G},
  title = {Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide},
  journal = {Human Gene Therapy Clinical Development},
  year = {2014},
  doi = {10.1089/hum.2014.022}
}
Kostenlos starten →